Phosphatidylserine (PS) is a phospholipid that sits in the membrane of every cell in your body, but it's most concentrated in the brain. People take it for two reasons: to blunt cortisol when they're chronically stressed or training hard, and to support memory and focus as they get older. Both effects show up in trials, both are modest, and both take consistent daily use rather than acute dosing.
The practical use case is narrow but legitimate. If you're under sustained stress (high training load, demanding job, sleep debt, perimenopausal cortisol creep), 300-400 mg daily can take some of the edge off the cortisol curve and help with the wired-but-tired feeling. If you're over 50 and noticing the early word-finding, name-recall, mental-fatigue stuff, the same dose has the best evidence base of any single nootropic for slowing that decline. It's not stimulating, it's not fast-acting, and you won't feel it the way you feel caffeine. The signal is what doesn't happen.
Deep-dive
PS makes up roughly 10-20% of the brain's phospholipids and is concentrated on the inner leaflet of neuronal cell membranes, where it does several jobs at once. It maintains membrane fluidity, which determines how well receptors and ion channels function. It anchors signalling proteins to the membrane. It's required for vesicle fusion at the synapse, which is the physical step where neurotransmitters get released. And on the cell surface, externalised PS acts as an "eat me" signal that lets microglia clear damaged or dying cells, which is part of how the brain prunes synapses and clears debris.
Brain PS levels decline with age and the synthesis pathway becomes less efficient, which is one of the reasons cognitive trials in older adults consistently show benefit while trials in young, healthy subjects often show nothing. Whether oral PS actually crosses the blood-brain barrier in meaningful amounts is still an open question, but plasma PS does rise after dosing and downstream effects on cortisol, mood, and cognition are reproducible enough that the mechanism is probably indirect: PS in peripheral tissues changes signalling, inflammation, and stress hormone output, and those changes propagate centrally.
Cortisol and the HPA axis. This is the most robust mechanistic finding. PS appears to blunt ACTH release at the pituitary, which reduces downstream cortisol output from the adrenals. The original 1990 trial gave 50-75 mg of bovine cortex PS intravenously to healthy men before cycle ergometer exercise and found significantly reduced ACTH and cortisol responses without affecting growth hormone or prolactin. A follow-up oral trial at 800 mg/day for 10 days replicated the effect. The most cited modern study used 600 mg/day of soy-derived PS for 10 days in healthy males and found peak cortisol after moderate-intensity cycling was reduced by 39% and the testosterone:cortisol ratio improved by 184% versus placebo. Effect sizes drop at lower doses and the response isn't universal, one downhill running trial at 750 mg/day found no cortisol attenuation after exhaustive eccentric exercise, suggesting the effect may have a ceiling once stress exceeds a certain intensity.
Cognitive function and memory. The strongest data is in older adults with mild cognitive complaints. A 2022 meta-analysis of nine trials in elderly subjects with cognitive decline found PS produced statistically significant improvements in memory, mostly at 300 mg/day for 12+ weeks. A 2024 trial in 177 Chinese adults with mild cognitive impairment found PS supplementation improved cognitive performance with effects that tracked changes in serum DHA and neurotransmitter markers. Trials in young healthy adults are mixed, some show working memory and processing speed gains, most show minimal effect. The Alzheimer's Drug Discovery Foundation's review concluded the cognitive effects in healthy adults are real but small enough to be of debatable clinical relevance, while effects in age-associated memory impairment look more meaningful.
ADHD. A 2021 systematic review and meta-analysis of pediatric ADHD trials found PS at 200-300 mg/day produced a statistically significant effect on inattention symptoms (effect size 0.36) but not on hyperactivity-impulsivity or overall ADHD symptoms. The largest trial was a 30-week study of 200 ADHD children using PS-omega-3, which showed reduced restless/impulsive behavior and was well-tolerated with no growth or weight effects. Evidence quality is graded low overall, but the safety profile is strong enough that some pediatricians use it as an adjunct or first-line trial before stimulants.
Athletic performance and overtraining. PS has a small foothold here that mostly traces back to the cortisol effect. The 600 mg/day trial in cyclists showing the testosterone:cortisol ratio improvement is the strongest signal. An older study in resistance-trained males using 800 mg/day during two weeks of overreaching found reduced muscle soreness and better-preserved well-being scores versus placebo. A cycling time-to-exhaustion trial at 750 mg/day found exercise time at 85% VO2max increased from 7:51 to 9:51 minutes. Direct recovery effects (muscle damage markers, oxidative stress) haven't replicated. The honest read is that PS probably helps athletes who are accumulating stress faster than they're recovering, less so for acute performance.
Women. PS works the same way mechanistically in women, the cortisol-blunting effect doesn't depend on sex hormones. A 2014 trial in 40 women aged 18-45 with PMS found 400 mg PS plus 400 mg phosphatidic acid daily over three menstrual cycles significantly reduced PMS symptom severity (depressive symptoms, physical symptoms, productivity loss) compared to placebo, with reduced cortisol awakening response in the follicular phase by cycle 4. This is one of the few cortisol-modulating compounds with a positive women-specific PMS trial. For perimenopausal women dealing with stress-driven sleep disruption, evening cortisol elevation, or the abdominal weight gain that goes with chronic HPA activation, PS is one of the more defensible additions. No dose adjustment needed compared to men. Skip in pregnancy and breastfeeding, no human safety data.
Source matters. Original studies used PS extracted from bovine cortex (BC-PS), which most closely matches the structural composition of human brain PS. After mad cow disease in the 1990s, bovine PS was withdrawn over theoretical prion concerns and replaced with soy- and sunflower-derived PS. The molecular backbone is identical, but the fatty acid composition differs (bovine PS is richer in DHA, soy and sunflower PS have more linoleic acid). Most modern trials use soy PS at 300+ mg/day and effect sizes are slightly smaller than the original BC-PS work. Sunflower PS is chemically equivalent to soy PS minus the soy allergen risk. There's no strong evidence sunflower outperforms soy, the choice usually comes down to allergy profile and personal preference. PS conjugated with omega-3 (often marketed as Sharp-PS Gold or Vayarin) is the form used in most ADHD and elderly cognitive trials, the omega-3 component contributes its own effect.
Dosage:
- Standard daily dose: 300 mg/day, split as 100 mg three times with meals or 300 mg in a single evening dose. This is the dose with the most cognitive and cortisol data behind it
- Stress/cortisol focus: 400-600 mg/day, taken 1-2 hours before the stressor (training, demanding work day) or in the evening to support overnight cortisol normalisation. Most cortisol-blunting trials used 400-800 mg/day
- Cognitive support in older adults: 300 mg/day for at least 12 weeks before assessing effect. Below that dose or duration, expect nothing
- ADHD (paediatric or adult): 200-300 mg/day, often combined with omega-3, for at least 8-15 weeks. Effects are modest and primarily on inattention
- PMS: 400 mg PS plus 400 mg phosphatidic acid daily, taken throughout the cycle (not just luteal phase) for 2-3 cycles before assessing
- Take with meals containing fat. PS is fat-soluble and absorption improves significantly with dietary fat. Avoid taking on an empty stomach
- Timing: Evening dose works best if your goal is cortisol normalisation, sleep, or stress recovery. Split dosing (with meals) is fine if you're targeting cognitive support. Some people get insomnia at higher doses regardless of timing, more on that below
- Forms: Soy and sunflower PS are equivalent in effect, sunflower is the choice for soy-sensitive individuals. PS-omega-3 (Sharp-PS Gold, Vayarin) is the form used in elderly cognitive and ADHD trials and is reasonable if you want both effects in one capsule. Bovine PS is no longer commercially available in most markets. Avoid "PS complex" products that hide the actual PS dose behind a proprietary blend
- Onset: Cortisol effects can show within a week. Cognitive effects need 8-12 weeks of consistent dosing. There's no acute single-dose benefit for cognition
Here's what you can expect:
The honest answer is, not much that you'll consciously feel. PS isn't subjectively psychoactive. It's not a stimulant, it's not relaxing, and there's no come-up. The signal is what stops happening: less of the wired-but-tired feeling at the end of a stressful week, less of the late-night cortisol spike that wakes you at 3 a.m., a slightly steadier baseline mood through a heavy training block. Most people who use it correctly describe it as something they noticed only when they ran out and went a couple of weeks without.
If you're using it for cognitive support and you're under 50 with no real complaints, you'll probably notice nothing. The benefit there is preventive and slow. If you're over 50 with mild memory complaints, expect modest improvements in word recall, name-finding, and mental fatigue across 12+ weeks of consistent use. Don't expect dramatic change.
If you're using it for stress and cortisol, the effect is more practical: better sleep onset, less stress-eating in the evening, easier recovery between hard sessions. Athletes report less of the post-training crash. Women using it for PMS often describe the worst week of their cycle as feeling more like a normal week, not pain-free, just less of the emotional and energetic bottoming out.
If you feel nothing after 8-12 weeks at 300+ mg/day, you're probably not in the population that responds, and continuing to take it isn't going to change that.
Side effects & risks:
- Insomnia and overstimulation. Counterintuitive for a cortisol-blunting compound, but the most reported side effect at doses above 300 mg/day is sleep disruption, especially when taken late in the day. If sleep gets worse, drop the dose or move it to morning
- GI discomfort. Mild nausea, bloating, or loose stools, usually at higher doses or when taken on an empty stomach. Take with food and split the dose
- Headache. Occasional, usually transient and dose-dependent
- Mild blood pressure reduction. Generally not clinically significant but worth knowing if you're on antihypertensives or already running low BP
- Bleeding risk. PS has demonstrated mild anticoagulant effects in vitro and in animal studies, inhibiting thrombin formation in the prothrombin complex. Clinically meaningful bleeding from PS supplementation alone hasn't been reported, but the theoretical interaction matters if you're on warfarin, heparin, clopidogrel, or stacking with high-dose fish oil, ginkgo, garlic, or vitamin E. If you're on any anticoagulant or antiplatelet, talk to your doctor before starting
- Cholinergic medication interactions. PS supports acetylcholine release, so it can theoretically amplify the effect of cholinergic drugs (donepezil, rivastigmine, galantamine for Alzheimer's, or pyridostigmine for myasthenia gravis) and reduce the effect of anticholinergics. Most relevant for older adults already on dementia medication
- Pregnancy and breastfeeding. No human safety data. Skip it
- Soy allergy. Use sunflower-derived PS instead. Both work
- Bovine source prion concerns. Bovine cortex PS was the original research-grade form and still has the cleanest cognitive data, but theoretical prion transmission risk pulled it from the market. If you find a bovine PS product in circulation (rare), the risk is genuinely low but not zero, and the soy/sunflower equivalents are nearly as well-studied at this point
- Long-term safety. Trials of up to 30 weeks at 300 mg/day in elderly adults and similar duration in ADHD children show no significant adverse events, no impact on growth, weight, blood markers, or vital signs. Beyond 6-12 months at higher doses, data thins out
Blood markers
Morning cortisol (AM serum, ideally between 7-9 a.m.), or better, a 4-point salivary cortisol curve if you suspect HPA dysregulation. Useful baseline if your reason for taking PS is stress, sleep disruption, or the wired-but-tired pattern. Recheck at 8-12 weeks to confirm the curve is normalising. Without a baseline you're guessing.
DHEA-S, paired with cortisol gives a fuller picture of HPA axis state. A high cortisol:DHEA-S ratio is the biochemical fingerprint of chronic stress, and that's the population PS helps most.
Coagulation panel (PT/INR, PTT) if you're on any anticoagulant or antiplatelet medication, before starting and at 4-6 weeks. Not for the general population.
Lipid panel and fasting glucose at baseline if you're using PS in the context of HPA dysregulation, since chronic high cortisol drives both insulin resistance and dyslipidaemia, and PS is one piece of the broader metabolic picture.
For most people taking PS at 300 mg/day for general cognitive support or moderate stress management, no specific bloodwork is needed.
Sold as a dietary supplement in most countries without prescription.
